Cargando…

Cost-Effectiveness of Adolescent Pertussis Vaccination for The Netherlands: Using an Individual-Based Dynamic Model

BACKGROUND: Despite widespread immunization programs, a clear increase in pertussis incidence is apparent in many developed countries during the last decades. Consequently, additional immunization strategies are considered to reduce the burden of disease. The aim of this study is to design an indivi...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Vries, Robin, Kretzschmar, Mirjam, Schellekens, Joop F. P., Versteegh, Florens G. A., Westra, Tjalke A., Roord, John J., Postma, Maarten J.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2955521/ https://www.ncbi.nlm.nih.gov/pubmed/20976213 http://dx.doi.org/10.1371/journal.pone.0013392

Ejemplares similares

Cost-effectiveness of a male catch-up human papillomavirus vaccination program in the Netherlands
por: Simons, Joost J.M., et al.
Publicado: (2022)

Meningococcal Serogroup A, C, W(135) and Y Conjugated Vaccine: A Cost-Effectiveness Analysis in the Netherlands
por: Hepkema, Hiltsje, et al.
Publicado: (2013)

Seroprevalence of Pertussis in the Netherlands: Evidence for Increased Circulation of Bordetella pertussis
por: de Greeff, Sabine C., et al.
Publicado: (2010)

An Updated Analysis of the Impact of HPV Vaccination Based on Long-term Effectiveness in the Netherlands
por: Luttjeboer, Jos, et al.
Publicado: (2023)

Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands
por: Westra, Tjalke A, et al.
Publicado: (2013)

Vaccination process of immunocompromised patients in the Netherlands: Current challenges and potential solutions
por: de Laat, Cindy R., et al.
Publicado: (2023)

Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data.
por: de Melker, H E, et al.
Publicado: (2000)

Pertussis in The Netherlands: an outbreak despite high levels of immunization with whole-cell vaccine.
por: de Melker, H E, et al.
Publicado: (1997)

An evidence synthesis approach to estimating the incidence of symptomatic pertussis infection in the Netherlands, 2005–2011
por: McDonald, Scott A., et al.
Publicado: (2015)

Bordetella pertussis: an underreported pathogen in pediatric respiratory infections, a prospective cohort study
por: van den Brink, Gertrude, et al.
Publicado: (2014)

Pertussis hospitalizations among term and preterm infants: clinical course and vaccine effectiveness
por: van der Maas, Nicoline A. T., et al.
Publicado: (2019)

Age Related Differences in Dynamics of Specific Memory B Cell Populations after Clinical Pertussis Infection
por: van Twillert, Inonge, et al.
Publicado: (2014)

Cost-effectiveness of rotavirus vaccination in the Netherlands; the results of a consensus model
por: Rozenbaum, Mark H, et al.
Publicado: (2011)

Cost-effectiveness of ravulizumab compared with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria in the Netherlands
por: Quist, S. W., et al.
Publicado: (2023)

Modelling the impact of extended vaccination strategies on the epidemiology of pertussis
por: ROZENBAUM, M. H., et al.
Publicado: (2012)

Loss of Multi-Epitope Specificity in Memory CD4(+) T Cell Responses to B. Pertussis with Age
por: Han, Wanda G. H., et al.
Publicado: (2013)

Costs of clinical events in type 2 diabetes mellitus patients in the Netherlands: A systematic review
por: van Schoonhoven, Alexander V., et al.
Publicado: (2019)

Cost-effectiveness and budget impact of the fixed-dose dual bronchodilator combination tiotropium–olodaterol for patients with COPD in the Netherlands
por: van Boven, Job FM, et al.
Publicado: (2016)

Pertussis diagnostic practices of general practitioners in the Netherlands: A survey study
por: Heil, Jeanne, et al.
Publicado: (2019)

An update of “Cost-effectiveness of rotavirus vaccination in the Netherlands: the results of a Consensus Rotavirus Vaccine model”
por: Tu, Hong Anh T, et al.
Publicado: (2013)

Is Adding HCV Screening to the Antenatal National Screening Program in Amsterdam, The Netherlands, Cost-Effective?
por: Urbanus, Anouk T., et al.
Publicado: (2013)

More than 10 years after introduction of an acellular pertussis vaccine in infancy: a cross-sectional serosurvey of pertussis in the Netherlands
por: Versteegen, Pauline, et al.
Publicado: (2021)

The Cost-Effectiveness of Hepatitis C Virus Screening Strategies among Recently Arrived Migrants in the Netherlands
por: Al Khayat, Mohamed N.M.T., et al.
Publicado: (2020)

Hospitalization for pertussis: profiles and case costs by age
por: O'Brien, Judith A, et al.
Publicado: (2005)

Cost-effectiveness of finerenone in chronic kidney disease associated with type 2 diabetes in The Netherlands
por: Quist, Sara W., et al.
Publicado: (2023)

Current and Future Incidence and Costs of Osteoporosis-Related Fractures in The Netherlands: Combining Claims Data with BMD Measurements
por: Lötters, Freek J. B., et al.
Publicado: (2016)

Economic impact of childhood/adolescent ADHD in a European setting: the Netherlands as a reference case
por: Le, Hoa H., et al.
Publicado: (2013)

Cost-Effectiveness of Dabigatran Compared to Vitamin-K Antagonists for the Treatment of Deep Venous Thrombosis in the Netherlands Using Real-World Data
por: van Leent, Merlijn W. J., et al.
Publicado: (2015)

Cost-effectiveness of screening smokers and ex-smokers for lung cancer in the Netherlands in different age groups
por: Al Khayat, Mohamed N. M. T., et al.
Publicado: (2022)

Enhanced Bordetella pertussis acquisition rate in adolescents during the 2012 epidemic in the Netherlands and evidence for prolonged antibody persistence after infection
por: van der Lee, Saskia, et al.
Publicado: (2017)

Equity in human papilloma virus vaccination uptake?: sexual behaviour, knowledge and demographics in a cross-sectional study in (un)vaccinated girls in the Netherlands
por: Mollers, Madelief, et al.
Publicado: (2014)

The Use of Innovative Two-Component Cluster Analysis and Serodiagnostic Cut-Off Methods to Estimate Prevalence of Pertussis Reinfections
por: van Twillert, Inonge, et al.
Publicado: (2016)

Cost-effectiveness of hepatitis C virus screening, and subsequent monitoring or treatment among pregnant women in the Netherlands
por: Eijsink, Job F. H., et al.
Publicado: (2020)

Dabigatran for the Treatment and Secondary Prevention of Venous Thromboembolism; A Cost-Effectiveness Analysis for the Netherlands
por: Stevanović, J., et al.
Publicado: (2016)

Cost effectiveness of vaccination against pandemic influenza in European countries: mathematical modelling analysis
por: Lugnér, Anna K, et al.
Publicado: (2012)

Responses to an acellular pertussis booster vaccination in children, adolescents, and young and older adults: A collaborative study in Finland, the Netherlands, and the United Kingdom
por: Versteegen, Pauline, et al.
Publicado: (2021)

Community‐acquired pathogens associated with prolonged coughing in children: a prospective cohort study
por: Versteegh, F. G. A., et al.
Publicado: (2005)

Incidence and Reproduction Numbers of Pertussis: Estimates from Serological and Social Contact Data in Five European Countries
por: Kretzschmar, Mirjam, et al.
Publicado: (2010)

Cross-border comparison of antibiotic prescriptions among children and adolescents between the north of the Netherlands and the north-west of Germany
por: Dik, Jan-Willem H., et al.
Publicado: (2016)

Corrigendum to ‘Responses to an acellular pertussis booster vaccination in children, adolescents, and young and older adults: A collaborative study in Finland, the Netherlands, and the United Kingdom’
por: Versteegen, Pauline, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ph8pu6fnbm5m8oouctl9tcfq7c